US Stock MarketDetailed Quotes

APP Applovin

Watchlist
  • 331.000
  • -46.060-12.22%
Close Feb 26 16:00 ET
  • 345.750
  • +14.750+4.46%
Pre 06:12 ET
112.55BMarket Cap73.07P/E (TTM)

Applovin Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Applovin Q4 2024 Earnings Date

Highlights | A substantial increase in total revenue, reaching $4.7 billion for the year, a 43% rise compared to the previous year

Currency：USDFeb 12, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.26B
1.37B
+110.20M
Beat Est.
+32.45%
+44.01%
+8.73%
EPS
1.26
1.73
+0.47
Beat Est.
+156.71%
+253.06%
+37.53%
Analyst Rating
Strong Buy

Feb 27, 2025

Applovin Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.417B--
--2025/Q1-- / 1.380B--
Feb 12, 20252024/Q41.373B / 1.263B--
Nov 6, 20242024/Q31.198B / 1.131B--
Aug 7, 20242024/Q21.080B / 1.083B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.417B--
--2025/Q1-- / 1.380B--
Feb 12, 20252024/Q41.373B / 1.263B
AppLovin Q4 2024 earnings conference call
Feb 12 16:00
Replay
Nov 6, 20242024/Q31.198B / 1.131B--
Aug 7, 20242024/Q21.080B / 1.083B--

Unlock Free Earnings Estimates

Applovin Earnings Reports

  • Applovin | 8-K: AppLovin Announces Fourth Quarter and Full Year 2024 Financial Results

    Feb 12 16:12 ET

  • Applovin | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 17:07 ET

  • Applovin | 8-K: AppLovin Announces Third Quarter 2024 Financial Results

    Nov 6, 2024 16:14 ET

  • Applovin | 10-Q: Q2 2024 Earnings Report

    Aug 7, 2024 17:08 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +16.49%
    Hutchmed (China)
    HCM
    +6.29%
    Workday
    WDAY
    +6.22%
    DexCom
    DXCM
    +1.80%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +0.62%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 27, 2025

    Strong Buy

    • Buy

      78.95%

    • Hold

      21.05%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme DeepSeek Beneficiaries
    DeepSeek Beneficiaries
    Intraday-0.22%